Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021

SELL
$135.08 - $161.1 $99,553 - $118,730
-737 Closed
0 $0
Q1 2021

May 07, 2021

BUY
$137.51 - $190.8 $65,042 - $90,248
473 Added 179.17%
737 $100,000
Q4 2020

Jan 13, 2021

BUY
$164.63 - $211.93 $2,469 - $3,178
15 Added 6.02%
264 $46,000
Q3 2020

Nov 12, 2020

BUY
$145.95 - $195.69 $36,341 - $48,726
249 New
249 $49,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Sowell Financial Services LLC Portfolio

Follow Sowell Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sowell Financial Services LLC with notifications on news.